, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
should participate as an amicus curiae or intervenor in non-NRC litigation, including matters raising preemption and statutory...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...
;develop affirmative litigation strategies;assist with the development and coordination of amicus briefs for appropriate case...
, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease...